Jia Shang

4.7k total citations
107 papers, 1.5k citations indexed

About

Jia Shang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Jia Shang has authored 107 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Epidemiology, 54 papers in Hepatology and 23 papers in Molecular Biology. Recurrent topics in Jia Shang's work include Hepatitis C virus research (41 papers), Liver Disease Diagnosis and Treatment (40 papers) and Hepatitis B Virus Studies (37 papers). Jia Shang is often cited by papers focused on Hepatitis C virus research (41 papers), Liver Disease Diagnosis and Treatment (40 papers) and Hepatitis B Virus Studies (37 papers). Jia Shang collaborates with scholars based in China, United States and Germany. Jia Shang's co-authors include Yi Kang, Zhenxing Xie, Chaoran Chen, Guangli Lu, Yanli Zeng, Zhen Wu, Zhen Peng, Ke Chen, Qing Xie and Ping Yang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Jia Shang

105 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jia Shang China 23 563 465 404 180 137 107 1.5k
Ashraf Mohamadkhani Iran 23 520 0.9× 448 1.0× 330 0.8× 219 1.2× 164 1.2× 91 1.6k
Lori Showalter United States 15 867 1.5× 1.0k 2.2× 783 1.9× 177 1.0× 77 0.6× 29 2.5k
Byeong Gwan Kim South Korea 22 834 1.5× 388 0.8× 461 1.1× 132 0.7× 103 0.8× 92 2.0k
M Sata Japan 28 868 1.5× 740 1.6× 780 1.9× 206 1.1× 93 0.7× 124 2.8k
Ana I. Burguete-García Mexico 22 561 1.0× 615 1.3× 146 0.4× 179 1.0× 53 0.4× 79 1.7k
Xing Liu China 17 273 0.5× 272 0.6× 131 0.3× 123 0.7× 91 0.7× 64 1.2k
Xiaoming Cheng China 21 528 0.9× 496 1.1× 298 0.7× 118 0.7× 748 5.5× 67 1.9k
Lorenzo Polimeno Italy 25 407 0.7× 552 1.2× 554 1.4× 74 0.4× 62 0.5× 55 1.8k
Arturo Panduro Mexico 29 1.3k 2.3× 530 1.1× 1.2k 2.9× 105 0.6× 198 1.4× 161 2.7k

Countries citing papers authored by Jia Shang

Since Specialization
Citations

This map shows the geographic impact of Jia Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Shang more than expected).

Fields of papers citing papers by Jia Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Shang. The network helps show where Jia Shang may publish in the future.

Co-authorship network of co-authors of Jia Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Shang. A scholar is included among the top collaborators of Jia Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Shang. Jia Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Hui, Hai Li, Guohong Deng, et al.. (2025). A novel model for identifying infections in patients with AoCLD: a nationwide, multicenter, prospective cohort study. QJM. 118(7). 489–500. 1 indexed citations
3.
Liu, Mian, Lichun Qiao, Jia Shang, et al.. (2025). Disease burden of ischemic heart disease attributable to lead exposure in China from 1990 to 2019, and projections until 2030. International Journal of Environmental Health Research. 35(10). 2855–2865. 2 indexed citations
4.
Kong, Nan, Qiran Zhang, Xiaohong Gao, et al.. (2024). Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon α-2b for 48 weeks. Hepatology International. 19(2). 358–367. 1 indexed citations
5.
6.
7.
8.
Wu, Sijia, Jia Shang, Yuanyuan Li, et al.. (2023). The effects of lipoic acid on respiratory diseases. International Immunopharmacology. 116. 109713–109713. 9 indexed citations
9.
Nan, Yuemin, et al.. (2022). Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 6 indexed citations
10.
Xu, Xiaodong, Ji‐Bo Wang, Jia Shang, et al.. (2022). Size- and density-dependent acoustic differential bioassembly of spatially-defined heterocellular architecture. Biofabrication. 15(1). 15019–15019. 25 indexed citations
11.
Shang, Jia, et al.. (2022). Effects of Lycopene Attenuating Injuries in Ischemia and Reperfusion. Oxidative Medicine and Cellular Longevity. 2022(1). 9309327–9309327. 8 indexed citations
12.
Shang, Jia, Bin Li, Wen Zhao, et al.. (2022). Sevoflurane promotes premature differentiation of dopaminergic neurons in hiPSC-derived midbrain organoids. Frontiers in Cell and Developmental Biology. 10. 941984–941984. 10 indexed citations
13.
Wan, Xiao, Haitao Huang, Jia Shang, et al.. (2021). Willingness and influential factors of parents of 3-6-year-old children to vaccinate their children with the COVID-19 vaccine in China. Human Vaccines & Immunotherapeutics. 17(11). 3969–3974. 36 indexed citations
14.
Peng, Zhen, Fujiao Duan, Jingjing Yin, et al.. (2019). Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test. Journal of Translational Medicine. 17(1). 347–347. 12 indexed citations
15.
Sun, Yadong, Fujiao Duan, Weigang Liu, et al.. (2018). Comprehensive Assessment of the Relationship Between MicroRNA-124 and the Prognostic Significance of Cancer. Frontiers in Oncology. 8. 252–252. 2 indexed citations
16.
17.
Rao, Huiying, Lai Wei, Hong Li, et al.. (2015). Prevalence of abnormal glycometabolism in treatment‐naive patients with hepatitis C virus infection in a C hinese H an population. Journal of Gastroenterology and Hepatology. 30(6). 1049–1056. 5 indexed citations
18.
19.
Shang, Jia, Xiaoyuan Xu, Xinyue Chen, et al.. (2015). Efficacy and related factors of pegylated interferon α-2a plus ribavirin therapy for chronic hepatitis C in non-responders. 8(3). 232–237. 1 indexed citations
20.
Feng, Bo, Ruifeng Yang, Qing Xie, et al.. (2014). Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection. BMC Gastroenterology. 14(1). 47–47. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashraf Mohamadkhani Breakdown of academic impact, for papers by Lori Showalter Breakdown of academic impact, for papers by Byeong Gwan Kim Breakdown of academic impact, for papers by M Sata Breakdown of academic impact, for papers by Ana I. Burguete-García Breakdown of academic impact, for papers by Xing Liu Breakdown of academic impact, for papers by Xiaoming Cheng Breakdown of academic impact, for papers by Lorenzo Polimeno Breakdown of academic impact, for papers by Arturo Panduro
Rankless by CCL
2026